Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial
Clinical Diabetes · 15.07.2025 · 43 (3) · 388-398
DOI: 10.2337/cd24-0104 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Diabetes, online erschienen am 24.02.2025. Verfasst von Sean M Oser und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.
Autor:innen und Institutionen
- Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
- Diabetes Research Center, Massachusetts General Hospital, Boston, MA.
- Beta Bionics, Concord, MA.
- Biostatistics Center, Massachusetts General Hospital, Boston, MA.
- Department of Biomedical Engineering, Boston University, Boston, MA.
ORCID-Profile: Sean M Oser, Jessica A Parascando
Förderung
- Leona M. and Harry B. Helmsley Charitable Trust
Zitieren
APA
Oser, S. M., Putman, M. S., Russell, S. J., Westfeldt, E. B., Huss, K. B., Prince, B. K., Parascando, J. A., O'Connor, M. Y., Sabean, A., Ashley, A. L., Greaux, E. G., Bartholomew, R. J., Gaston, S., Anandakugan, N., Zheng, H., Balliro, C. A., Hillard, M. A., Damiano, E. R., & Oser, T. K. (2025). Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial. Clinical Diabetes, 43(3), 388-398. https://doi.org/10.2337/cd24-0104
Vancouver
Oser SM, Putman MS, Russell SJ, Westfeldt EB, Huss KB, Prince BK, et al. Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial. Clinical Diabetes. 2025;43(3):388-398. doi:10.2337/cd24-0104
BibTeX
@article{Oser2025,
author = {Oser, Sean M and Putman, Melissa S and Russell, Steven J and Westfeldt, Elizabeth B and Huss, Kelsey B and Prince, Britney K and Parascando, Jessica A and O'Connor, Mollie Y and Sabean, Amy and Ashley, Annabelle L and Greaux, Evelyn G and Bartholomew, Rachel J and Gaston, Sarah and Anandakugan, Nillani and Zheng, Hui and Balliro, Courtney A and Hillard, Mallory A and Damiano, Edward R and Oser, Tamara K},
title = {Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial},
journal = {Clinical Diabetes},
year = {2025},
volume = {43},
number = {3},
pages = {388--398},
doi = {10.2337/cd24-0104}
}
EUVIMED